Search Results:　 1-20 of 498

横山 七重 , 小仲 靖江 , 山崎 越子 , 西川 いと , 東 貴子 , 林 由香 , ヨコヤマ ナナエ , コナカ ヤスエ , ヤマサキ エツコ , ニシカワ イト , ヒガシ タカコ , ハヤシ ユカ , Yokoyama Nanae , Konaka Yasue , Yamasaki Etsuko , Nishikawa Ito , Higashi Takako , Hayashi Yuka

… In Kumamoto city, the rate of renal failure patients is the worst in Japan, and medical costs for life-style related diseases are more rapidly increasing than other ordinance-designated cities. …

熊本大学政策研究 4, 91-101, 2013-03-29

IR

清水 徹男

日本精神科病院協会雑誌 31(11), 1170-1174, 2012-11-00

山岸 俊夫 , 岡村 州博

共済医報 61(3), 242-250, 2012-08-00

Ichushi Web

KOMAKI Yuga , SAKIYAMA Toshio , SETOYAMA Hitoshi , FUJITA Hiroshi , FUNAKAWA Keita , IWAKIRI Yuji , UCHIZONO Hitoshi , TSUBOUCHI Hirohito

日本消化器内視鏡学会雑誌 = Gastroenterological endoscopy 54(6), 1827-1836, 2012-06-20

References (58)

HAMADA Naokazu , NISHI Yoshihiro , TAJIRI Yuji , SETOYAMA Kentaro , KAMIMURA Ryozo , MIYAHARA Kenkichi , NURUKI Norihito , HOSODA Hiroshi , KANGAWA Kenji , KOJIMA Masayasu , MIFUNE Hiroharu

Background: Ghrelin is an acylated peptide hormone mainly secreted from the stomach. When administrated externally it modulates vascular tone mainly through the regulation of autonomic nerve activity. …

Circulation Journal 76(6), 1423-1429, 2012-05-25

J-STAGE CrossRef References (45)

Namiki Mikio , Ueno Satoru , Kitagawa Yasuhide , Fukagai Takashi , Akaza Hideyuki

… On the other hand, there has been an increase in criticism of hormonal therapy, because hormonal therapy is supposed to induce adverse effects such as cardiovascular disease. … First, we showed that primary hormonal therapy can achieve long-term control of localized prostate cancer in some cases and that quality of life of patients receiving hormonal therapy is rather better than previously thought. …

Asian Journal of Andrology 14(3), 451-457, 2012-05-00

IR CrossRef

HAYASHI Norio , KIYOSAWA Kendo , TSUBOUCHI Hirohito , OKANOUE Takeshi , KUMADA Hiromitsu

B型慢性肝炎に対するペグインターフェロンアルファ-2a（PEG-IFNα-2a）の有効性，安全性を検討した． HBe抗原陽性例はPEG-IFNα-2a 90 μg，180 μg/週の各々24週投与，48週投与又は天然型IFNα6 MIU週3回24週投与（HLBI群）の5群に無作為割付けし，投与終了後24週時のALT正常化，HBeセロコンバージョン及びHBV-DNA量抑制の複合評価で有効性を評価した …

Kanzo 53(3), 135-146, 2012-03-25

J-STAGE Ichushi Web CrossRef References (10)

Ishibashi Hiromi , Nakanuma Yasuni , Ueno Yoshiyuki , Egawa Hiroto , Koike Kazuhiko , Komori Atsumasa , Sakisaka Shotaro , Shimoda Shinji , Shirabe Ken , Zeniya Mikio , Soejima Yuji , Takeyama Yasuaki , Tanaka Atsushi , Nakamuta Makoto , Nakamura Minoru , Harada Kenichi , Fukushima Nobuyoshi , Maehara Yoshihiko , Morizane Toshio , Tsubouchi Hirohito

Kanzo 53(10), 633-686, 2012

J-STAGE Ichushi Web CrossRef